Chondrogenic capacity of CD105-positive synovium-derived mesenchymal stem cells

Wen-shuai Fan,Jia Liu,Jianfeng Pan,Chen Chen,Zuoqin Yan,Chang'an Guo
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2015.01.036
2015-01-01
Abstract:Objective To evaluate the proliferation and chondrogenic differentiation of CD105 + enriched synovium-derived mesenchymal stem cells (SMSCs).Methods The synovium-derived mesenchymal stem cells (SMSCs) were obtained from human synovium by enzyme digestion and CD105-positive (CD105 +) ceils were enriched using fluorescence activated cell sorting (FACS).The proliferation ability of CD105 + SMSCs was measured through WST-1 at day 3 and day 7.The chondrogenic differentiation of CD105 + SMSCs was detected by toluidine blue staining for aggrecan and immunohistochemistry staining for type Ⅱ collagen after 21 days introduction.Results The synovium-derived mesenchymal stem cells (SMSCs) showed star or spindle shape.No obvious differences in morphology were noted after sorting.Immunofluorescence staining showed that there were more CD105 + cells in the sorted group than the unsorted.There was statistical difference between sorted and unsorted cells at day 3 (0.376 ± 0.012,0.329±0.012) andday7 (0.581 ±0.009,0.524 ±0.007) on theA value by WST-1 (P<0.05).The toluidine blue staining for aggrecan and immunohistochemistry staining for type Ⅱ collagen were more and stronger in sorted cells than unsorted after 21 days chondrogenic differentiation,which indicated that CD105 + SMSCs synthesized more cartilage extracellular matrix.Conclusion The CD105 + SMSCs have stronger proliferation ability and chondrogenic capacity,which may be promising cell sources for cartilage tissue engineering.
What problem does this paper attempt to address?